Oncogene and tumour suppressor gene products during trophoblast differentiation in the first trimester

Molecular Human Reproduction

Volumn 4, Issue 5, 1998, Pages 477-481

  Quenby, S ^a   Brazeau, C ^a   Drakeley, A ^a   Lewis Jones, D I ^a   Vince, G ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Apoptosis; Pregnancy; Trophoblast; Tumour suppressor genes

Indexed keywords

GENE PRODUCT;

ARTICLE; CELL DIFFERENTIATION; EMBRYO; EMBRYO DEVELOPMENT; FIRST TRIMESTER PREGNANCY; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; ONCOGENE; PRIORITY JOURNAL; PROTO ONCOGENE; TROPHOBLAST; TUMOR SUPPRESSOR GENE;

APOPTOSIS; CELL DIFFERENTIATION; DECIDUA; DNA DAMAGE; FEMALE; FETAL PROTEINS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENES, TUMOR SUPPRESSOR; HUMANS; KERATINS; ONCOGENES; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PROTO-ONCOGENE PROTEINS; TROPHOBLASTS;

EID: 0031746540     PISSN: 13609947     EISSN: None     Source Type: Journal    
DOI: 10.1093/molehr/4.5.477     Document Type: Article

References (30)

1. Arends, R. (1995) How do cancer cells die? Apoptosis and its role in neoplastic progression. In Leake, R., Gore, M. and Ward R.H. (eds), The Biology of Gynaecological Cancer RCOG Press, London, 415 pp.
2. Alberts, B., Bray, D., Lewis, J. et al. (1994) Molecular Biology of The Cell. Garland Publishing, New York, USA, 1294 pp.
3. Bagg, A. and Cossman, J. (1993). Bcl-2: Physology and role in neoplasia. In Benz, C. and Liu, E. (eds), Oncogenes and Tumour Supressor Genes in Human Malignancies Kluwer Academic Publishers, Boston, USA, 540 pp.
4. Bukovsky, A., Caudle, M.R., Keenan, J.A. et al. (1995) Expression of cell-cycle regulatory proteins (p53, prb) in the human female genital-tract J. Assist. Reprod. Genet., 12, 123-131.
5. Diebold, J., Arnholt, H., Lai, M.D. et al. (1991) c-myc expression in early human placenta - a critical evaluation of its localization. Virch. Arch. B Cell. Pathol., 61, 65-73.
6. Hamilton W.J., Boyd J.D. and Mossmon H.W. (eds) (1962) Human Embryology, Prenatal Development Form and Function. Heffer and Sons, Cambridge, UK, 200 pp.
7. Hunt, J.S., Vassmer, D., Ferguson, T.A., et al., (1997) Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the conceptus. J. Immunol., 158, 4211-4218.
8. Jack, A.S., Kerr, I B., Evan, G et al. (1986) The distribution of the c-myc oncogene product in malignant lymphomas and various normal tissues as demonstrated by immunohistochemistry. Br. Cancer J., 53, 713-719.
9. Jokhi, P.P., King, A. and Loke, Y.W. (1994) Reciprocal expression of epidermal growth-factor receptor (egf-r) and c-erb-2 by noninvasive and invasive human trophoblast populations. Cytokine, 6, 433-442.
10. Kim, C.J., Choe, Y.J., Yoon, B.H. et al. (1995) Patterns of bcl-2 expression in placenta. Path. Res. Pract., 191, 1239-1244.
11. King, A., Jokhi, P.P., Smith, S et al (1995) Screening for cytokine messenger-RNA in human villous and extravillous trophoblasts using the reverse-transcriptase polymerase chain-reaction (RT-PCR), Cytokine, 7, 364-371.
12. Lea, R.G., Al Sharekh, N., Tulppala, M and Critchley, H.O.D. (1997) The immunolocalization of bcl-2 at the maternal-fetal interface in healthy and failing pregnancies. Hum. Reprod., 12, 153-158.
13. Matsumura, T., Doki, K., Takansani, A. et al. (1990) Alteration and enhanced expression of the c-myc oncogene in human colorectal carcinomas. Path. Res. Ab., 186, 205-211.
14. Marzusch, K., Ruck, P., Horny, H.P. et al. (1995) Expression of the p53 tumor-suppressor gene m human placenta - an immunohistochemical study. Placenta, 16, 101-104.
15. Milner, J. (1991) The role of p53 in normal control of cell proliferation. Curr Opin. Cell. Biol., 3, 282-286.
16. Ohlsson, R. and Pfeifer-Ohlsson, S. (1986) myc expression in vivo during human embryogenesis. Curr. Top. Microbiol. Immunol., 132, 272-279.
17. Ohlsson, R., Glaser, A., Holmgren, L. et al (1993) The Molecular Biology of Placental Development. In Redman, C.W G., Sargent, I L. and Starkey, P.M. (eds), The Human Placenta Blackwell Scientific Publications, Oxford, UK, 598 pp
18. Pfeifer-Ohlsson, S., Goustin, A.S., Rydnert, J. et al (1984) Spatial and temporal patterns of cellular myc oncogene expression in developing human placenta: implications for embryonic cell proliferation Cell, 38, 585-596.
19. Polacarz, S.V., Hey, N.A., Stephensen, T.J. et al. (1989) c-myc oncogene product p62c-myc in ovarian mucinous neoplasms: immunohistochemical study correlated with malignancy. J. Clin. Pathol., 42, 148-152.
20. Redline, R.W. and Patterson, P. (1995) Pre-eclampsia is associated with an excess of proliferative immature intermediate trophoblast. Hum. Pathol., 26, 594-600.
21. Roncalli, M., Bulfamante, G., Viale et al. (1994) c-myc and tumor-suppressor gene-product expression in developing and term human trophoblast. Placenta, 15, 399-409
22. Runic, R., Lockwood, C.J., Yuehong M.A. et al. (1996) Expression of Fas ligand by human cytotrophoblasts: implications in placentation and fetal survival. J. Clin. Endocrinol Metab., 81, 319-3122.
23. Sakuragi, N., Matsuo, H., Coukos, G. et al. (1994) Differentiation-dependent expression of the bcl-2 protooncogene in the human trophoblast lineage. J. Soc. Gynecol. Invest., 1, 164-172.
24. Salmi, A., Ammala, M., Rutanen, E.-V. (1996) Proto-oncogenes c-jun and c-fos are down-regulated in human endometrium during pregnancy: relationship to oestrogen receptor status. Hum. Reprod., 12, 979-984.
25. Shi, S.-R., Cote, R.J., Taylor, C.R. (1997) Antigen retrevial immunohistochemistry past, present and future. J. Histochem. Cytochem., 45, 327-343.
26. Stahlebackdhal, M., Inoue, M., Zedenius, J. et al. (1995) Decreased expression of ras GTPase-activating protein in human trophoblastic tumors. Am. J. Pathol., 146, 1073-1078.
27. Stinchcomb, D. (1995) Constraining the cell cycle: regulating cell division and differentiation by gene therapy. Nature Med., 1, 1004-1006.
28. Uckan, D., Steele A., Cherry, et al. (1997) Trophoblasts express Fas ligand: a proposed mechanism for immune proviledge in placenta and maternal invasion. Mol Hum Reprod., 3, 655-662.
29. Weinberg, R. (1995) The retinoblastoma protein and cell cycle control. Cell. 81, 3323-3307.
30. Yonish-Rouch, E , Resnitzky, D., Lotem, J. et al. (1991) Wild type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin 6. Nature, 352, 345-349.